{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:59:39Z","timestamp":1790492379559,"version":"4.1.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1008121","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T18:25:03Z","timestamp":1575397503000},"page":"e1008121","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["ALVAC-HIV B\/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type"],"prefix":"10.1371","volume":"15","author":[{"given":"Luca","family":"Schifanella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan W.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Bissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin N.","family":"Doster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Vaccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia D.","family":"Tomaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Phogat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranajit","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6653-6655","authenticated-orcid":true,"given":"Celia C.","family":"LaBranche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangala","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung V.","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Washington-Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7362-3282","authenticated-orcid":true,"given":"Namal P. M.","family":"Liyanage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallas R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3675-3816","authenticated-orcid":true,"given":"Frank","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-9494","authenticated-orcid":true,"given":"Karin","family":"Lor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8990-158X","authenticated-orcid":true,"given":"David J.","family":"Venzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6786-2308","authenticated-orcid":true,"given":"William","family":"Magnanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8672-0962","authenticated-orcid":true,"given":"Michelle","family":"Metrinko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Breed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Ruprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2851-6589","authenticated-orcid":true,"given":"Genoveffa","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"ppat.1008121.ref001","unstructured":"IAVI. Clinical Trial Database: International AIDS Vaccine Initiative; 2019. Available from: https:\/\/www.iavi.org\/trials-database."},{"issue":"9653","key":"ppat.1008121.ref002","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"ppat.1008121.ref003","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":"Safety and efficacy of the HVTN 503\/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","volume":"11","author":"GE Gray","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"22","key":"ppat.1008121.ref004","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"SM Hammer","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"ppat.1008121.ref005","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand","volume":"194","author":"P Pitisuttithum","year":"2006","journal-title":"J Infect Dis"},{"issue":"23","key":"ppat.1008121.ref006","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"14","key":"ppat.1008121.ref007","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"7420","key":"ppat.1008121.ref008","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature11519","article-title":"Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2","volume":"490","author":"M Rolland","year":"2012","journal-title":"Nature"},{"key":"ppat.1008121.ref009","unstructured":"WHO. Data and Statistics. 2015."},{"issue":"5","key":"ppat.1008121.ref010","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/QAD.0b013e328342ff93","article-title":"Isolation W-UNfH, Characterisation. Global trends in molecular epidemiology of HIV-1 during 2000\u20132007","volume":"25","author":"J Hemelaar","year":"2011","journal-title":"AIDS"},{"key":"ppat.1008121.ref011","unstructured":"clinicaltrials.gov. Pivotal Phase 2b\/3 ALVAC\/Bivalent gp120\/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa (HVTN702). clinicaltrialsgov. 2016."},{"issue":"7","key":"ppat.1008121.ref012","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/S2352-3018(18)30071-7","article-title":"Subtype C ALVAC-HIV and bivalent subtype C gp120\/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1\/2 trial","volume":"5","author":"LG Bekker","year":"2018","journal-title":"Lancet HIV"},{"key":"ppat.1008121.ref013","unstructured":"Avert. HIV and AIDS in South Africa 2016. Available from: https:\/\/www.avert.org\/professionals\/hiv-around-world\/sub-saharan-africa\/south-africa."},{"key":"ppat.1008121.ref014","unstructured":"UNAIDS. Ending AIDS: Progress towards 90-90-90 targets2017 2018. Available from: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/Global_AIDS_update_2017_en.pdf."},{"key":"ppat.1008121.ref015","unstructured":"UNAIDS. Thailand 2016 Country Factsheet2017 2018. Available from: http:\/\/www.unaids.org\/en\/regionscountries\/countries\/thailand."},{"key":"ppat.1008121.ref016","unstructured":"Avert. HIV and AIDS in Thailand 2016. Available from: https:\/\/www.avert.org\/professionals\/hiv-around-world\/asia-pacific\/thailand."},{"key":"ppat.1008121.ref017","article-title":"HIV vaccine candidate activation of hypoxia and the inflammasome in CD14(+) monocytes is associated with a decreased risk of SIVmac251 acquisition","author":"M Vaccari","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"ppat.1008121.ref018","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm.4105","article-title":"Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition","volume":"22","author":"M Vaccari","year":"2016","journal-title":"Nat Med"},{"issue":"6309","key":"ppat.1008121.ref019","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.aag1276","article-title":"Sustained virologic control in SIV+ macaques after antiretroviral and alpha4beta7 antibody therapy","volume":"354","author":"SN Byrareddy","year":"2016","journal-title":"Science"},{"issue":"17","key":"ppat.1008121.ref020","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1128\/JVI.00558-06","article-title":"Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env","volume":"80","author":"RJ Song","year":"2006","journal-title":"Journal of virology"},{"issue":"22","key":"ppat.1008121.ref021","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG","volume":"110","author":"GD Tomaras","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"ppat.1008121.ref022","doi-asserted-by":"crossref","first-page":"e11689","DOI":"10.1371\/journal.pone.0011689","article-title":"R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models","volume":"5","author":"NB Siddappa","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"ppat.1008121.ref023","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/JVI.72.2.1052-1059.1998","article-title":"Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees","volume":"72","author":"S Zolla-Pazner","year":"1998","journal-title":"J Virol"},{"issue":"3","key":"ppat.1008121.ref024","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.qai.0000230318.40170.60","article-title":"An adenovirus-based HIV subtype B prime\/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains","volume":"43","author":"VR Gomez-Roman","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"ppat.1008121.ref025","doi-asserted-by":"crossref","first-page":"e1005101","DOI":"10.1371\/journal.ppat.1005101","article-title":"Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge","volume":"11","author":"I Tuero","year":"2015","journal-title":"PLoS Pathog"},{"issue":"6021","key":"ppat.1008121.ref026","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/315672a0","article-title":"Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins","volume":"315","author":"AD Luster","year":"1985","journal-title":"Nature"},{"issue":"2","key":"ppat.1008121.ref027","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"AB Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"issue":"2","key":"ppat.1008121.ref028","doi-asserted-by":"crossref","first-page":"e1006888","DOI":"10.1371\/journal.ppat.1006888","article-title":"Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection","volume":"14","author":"S Auclair","year":"2018","journal-title":"PLoS Pathog"},{"issue":"3","key":"ppat.1008121.ref029","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1128\/JVI.02386-13","article-title":"The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeys","volume":"88","author":"JE Teigler","year":"2014","journal-title":"J Virol"},{"issue":"7198","key":"ppat.1008121.ref030","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"SC Eisenbarth","year":"2008","journal-title":"Nature"},{"issue":"40\u201341","key":"ppat.1008121.ref031","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.1016\/j.vaccine.2006.06.011","article-title":"Comparative analysis of tropism between canarypox (ALVAC) and vaccinia viruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage","volume":"24","author":"Q Yu","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"ppat.1008121.ref032","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.1700698","article-title":"Priming and Activation of Inflammasome by Canarypox Virus Vector ALVAC via the cGAS\/IFI16-STING-Type I IFN Pathway and AIM2 Sensor","volume":"199","author":"F Liu","year":"2017","journal-title":"J Immunol"},{"issue":"1","key":"ppat.1008121.ref033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.qco.0000200293.45532.68","article-title":"HIV-1 subtypes: epidemiology and significance for HIV management","volume":"19","author":"AM Geretti","year":"2006","journal-title":"Curr Opin Infect Dis"},{"issue":"7","key":"ppat.1008121.ref034","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1473-3099(12)70088-9","article-title":"Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B\/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144","volume":"12","author":"ML Robb","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"ppat.1008121.ref035","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.4049\/jimmunol.1600674","article-title":"Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251","volume":"197","author":"SN Gordon","year":"2016","journal-title":"Acquisition. J Immunol"},{"issue":"3","key":"ppat.1008121.ref036","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1128\/JVI.02544-12","article-title":"Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial","volume":"87","author":"P Pegu","year":"2013","journal-title":"Journal of virology"},{"issue":"51","key":"ppat.1008121.ref037","doi-asserted-by":"crossref","first-page":"9538","DOI":"10.1016\/j.vaccine.2011.09.124","article-title":"Updated aluminum pharmacokinetics following infant exposures through diet and vaccination","volume":"29","author":"RJ Mitkus","year":"2011","journal-title":"Vaccine"},{"key":"ppat.1008121.ref038","unstructured":"ATSDR. Toxicological Profiles: Aluminum. Available from: https:\/\/www.atsdr.cdc.gov\/toxprofiles\/tp22-c1.pdf."},{"issue":"6284","key":"ppat.1008121.ref039","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","volume":"352","author":"MG Netea","year":"2016","journal-title":"Science"},{"issue":"8","key":"ppat.1008121.ref040","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/cid\/cix057","article-title":"Virus-driven Inflammation Is Associated With the Development of bNAbs in Spontaneous Controllers of HIV","volume":"64","author":"AS Dugast","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"8","key":"ppat.1008121.ref041","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1128\/JVI.80.8.3732-3742.2006","article-title":"Systemic immunization with an ALVAC-HIV-1\/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels","volume":"80","author":"R Pal","year":"2006","journal-title":"Journal of virology"},{"issue":"1\u20132","key":"ppat.1008121.ref042","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/08820139709048912","article-title":"NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics","volume":"26","author":"JW Romano","year":"1997","journal-title":"Immunol Invest"},{"issue":"6","key":"ppat.1008121.ref043","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.4049\/jimmunol.175.6.3502","article-title":"Vaccine-induced CD8+ central memory T cells in protection from simian AIDS","volume":"175","author":"M Vaccari","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"ppat.1008121.ref044","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/JVI.76.1.292-302.2002","article-title":"ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency","volume":"76","author":"R Pal","year":"2002","journal-title":"J Virol"},{"key":"ppat.1008121.ref045","article-title":"Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays","author":"DC Montefiori","year":"2005","journal-title":"Curr Protoc Immunol"},{"issue":"18","key":"ppat.1008121.ref046","doi-asserted-by":"crossref","first-page":"10163","DOI":"10.1128\/JVI.01161-13","article-title":"Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linking","volume":"87","author":"T Schiffner","year":"2013","journal-title":"J Virol"},{"issue":"9","key":"ppat.1008121.ref047","doi-asserted-by":"crossref","first-page":"e75665","DOI":"10.1371\/journal.pone.0075665","article-title":"Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial","volume":"8","author":"R Gottardo","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"ppat.1008121.ref048","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1128\/JVI.03635-14","article-title":"Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates","volume":"89","author":"X Shen","year":"2015","journal-title":"Journal of virology"},{"issue":"15","key":"ppat.1008121.ref049","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00281-18","article-title":"Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques","volume":"92","author":"S Singh","year":"2018","journal-title":"J Virol"},{"issue":"4","key":"ppat.1008121.ref050","doi-asserted-by":"crossref","first-page":"e0194266","DOI":"10.1371\/journal.pone.0194266","article-title":"Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant","volume":"13","author":"Y Wen","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"ppat.1008121.ref051","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/IAI.69.2.1151-1159.2001","article-title":"The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism","volume":"69","author":"M Ulanova","year":"2001","journal-title":"Infect Immun"},{"issue":"10","key":"ppat.1008121.ref052","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41591-018-0161-0","article-title":"Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV","volume":"24","author":"ME Ackerman","year":"2018","journal-title":"Nat Med"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1008531","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T04:32:43Z","timestamp":1612931563000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008121"}},"subtitle":[],"editor":[{"given":"Alexandra","family":"Trkola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1008121","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.ppat.1008531","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,3]]}}}